[HTML][HTML] Nonmetastatic castration-resistant prostate cancer: current challenges and trends

A Figueiredo, L Costa, MJ Maurício, L Figueira… - Clinical Drug …, 2022 - Springer
Prostate carcinoma is a highly prevalent biologically and clinically diverse disease,
generally associated with a consistent elevation of prostate-specific antigen levels …

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

A Figueiredo, L Costa, MJ Mauricio… - Clinical Drug …, 2022 - search.proquest.com
Prostate carcinoma is a highly prevalent biologically and clinically diverse disease,
generally associated with a consistent elevation of prostate-specific antigen levels …

[HTML][HTML] Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

A Figueiredo, L Costa, MJ Maurício… - Clinical Drug …, 2022 - ncbi.nlm.nih.gov
Prostate carcinoma is a highly prevalent biologically and clinically diverse disease,
generally associated with a consistent elevation of prostate-specific antigen levels …

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends.

A Figueiredo, L Costa, MJ Maurício… - Clinical Drug …, 2022 - europepmc.org
Prostate carcinoma is a highly prevalent biologically and clinically diverse disease,
generally associated with a consistent elevation of prostate-specific antigen levels …

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

A Figueiredo, L Costa, MJ Maurício… - Clinical drug …, 2022 - pubmed.ncbi.nlm.nih.gov
Prostate carcinoma is a highly prevalent biologically and clinically diverse disease,
generally associated with a consistent elevation of prostate-specific antigen levels …